Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the inclusion of circulating tumor DNA (ctDNA) testing in the National ...
You participate in end-to-end development through prototyping, validation, implementation, launch, and further iterations. You actively contribute to continuous integration efforts and improvements in ...